Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Cosman, Felicia, Crittenden, Daria B., Adachi, Jonathan D., Binkley, Neil, Czerwinski, Edward, Ferrari, Serge, Hofbauer, Lorenz C., Lau, Edith, Lewiecki, E. Michael, Miyauchi, Akimitsu, Zerbini, Cristiano A.F., Milmont, Cassandra E., Chen, Li, Maddox, Judy, Meisner, Paul D., Libanati, Cesar, Grauer, Andreas·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1607948

Cited by (1,001)

Items 801–900 of 1,001

Screening of key candidate genes and pathways for osteocytes involved in the differential response to different types of mechanical stimulation using a bioinformatics analysis
Ziyi Wang, Yoshihito Ishihara, Takanori Ishikawa, Mitsuhiro Hoshijima, Naoya Odagaki, Ei Ei Hlaing, Hiroshi Kamioka · 2018 · Journal of Bone and Mineral Metabolism
The osteoblast lineage
Natalie A. Sims, Thomas John Martin · 2019 · Elsevier eBooks
miR300 intervenes Smad3/β-catenin/RunX2 crosstalk for therapy with an alternate function as indicative biomarker in osteoporosis
Taruneet Kaur, Aijaz Ahmad John, Chandresh Sharma, Neelu Vashisht, Divya Ramesh Singh, Rajeev Kapila, Suman Kapila · 2020 · Bone
Risk of falls in patients with low bone mineral density
Luis Möckel · 2020 · Zeitschrift für Gerontologie und Geriatrie
Novel Aptamer-Based Small-Molecule Drug Screening Assay to Identify Potential Sclerostin Inhibitors against Osteoporosis
Chien-Ching Lee, Chao‐Ming Hung, Chung‐Hwan Chen, Yi‐Chiang Hsu, Yuan-Pin Huang, Tsung‐Bin Huang, Mon‐Juan Lee · 2021 · International Journal of Molecular Sciences
Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice
Kelsey A. Carpenter, Reid Davison, Shruti Shakthivel, Kyle Anderson, Frank C. Ko, Ryan D. Ross · 2021 · Bone
Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis
Tomonori Kobayakawa, Akiko Miyazaki, Jun A. Takahashi, Yukio Nakamura · 2022 · Clinical Nutrition ESPEN
Fragility Fractures of the Acetabulum: Current Concepts for Improving Patients’ Outcomes
Giuseppe Toro, Adriano Braile, Annalisa De Cicco, Raffaele Pezzella, Francesco Ascione, Antonio Benedetto Cecere, Alfredo Schiavone Panni · 2022 · Indian Journal of Orthopaedics
PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism
Yoshinori Matsumoto, Robert K. Rottapel · 2023 · Trends in Molecular Medicine
Osteoporosis treatment and pain relief: A scoping review
Marie‐Eva Pickering, Rose‐Marie Javier, Sandrine Malochet‐Guinamand, Gisele P Pickering, Jules Alexandre Desmeules · 2023 · European Journal of Pain
The Crucial Role of the WNT System in Bone Remodelling
Daniel Grigorie · 2018 · Acta Endocrinologica (Bucharest)
Spinal cord injury providers’ perspectives on managing sublesional osteoporosis
Frances M. Weaver, Bella Etingen, Marylou Guihan, Cara E. Ray, Michael M. Priebe, Stephen P. Burns, Laura D. Carbone · 2019 · Journal of Spinal Cord Medicine
Sclerostin and its role as a bone modifying agent in periodontal disease
Nisha Ashifa, Krishnan Viswanathan, Rajasekar Sundaram, Sivapragasam Srinivasan · 2021 · Journal of Oral Biosciences
Meta-Analysis of Clinical Fracture Risk Reduction of Antiosteoporosis Drugs: Direct and Indirect Comparisons and Meta-Regressions
Stewart Gary Albert, Emily M. Wood · 2021 · Endocrine Practice
Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?
Jad G. Sfeir, Robert J. Pignolo · 2021 · JBMR Plus
ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk‐JNK through DOK3
Yufeng Zhang, Sheng Zhang, Yi Wang, Zhiqiang Yang, Zhe Chen, Nengqiao Wen, Min Yang, Zan Huang, Yuanlong Xie, Lin Cai · 2021 · Oxidative Medicine and Cellular Longevity
Five-year risk of fracture and subsequent fractures among adults with cerebral palsy
Daniel G. Whitney, Gregory A. Clines, Aleda M. Leis, Michelle S. Caird, Edward A. Hurvitz · 2022 · Bone Reports
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents
Dominik Saul, Matthew T. Drake · 2021 · Endocrinology and Metabolism Clinics of North America
Management of postmenopausal osteoporosis
Ian R. Reid, Mark J Bolland · 2026 · Endocrine Reviews
Nonresponder Considerations for Romosozumab Treatment
Ayako Tominaga, Keiji Wada, Ken Okazaki, Hideharu Nishi, Yasushi Terayama, Shuji Shimamoto, Yasuteru Kodama, Yoshiharu Kato · 2023 · Calcified Tissue International
Novel insights into osteocyte and inter-organ/tissue crosstalk
Yan Zhang, Qingchang Chen · 2024 · Frontiers in Endocrinology
Association between P1NP value and increases in bone mineral density in patients with postmenopausal osteoporosis treated with romosozumab
Kyosuke Hattori, Yasuhide Kanayama · 2024 · Modern Rheumatology
A Multifunctional Therapeutic Strategy Using P7C3 as A Countermeasure Against Bone Loss and Fragility in An Ovariectomized Rat Model of Postmenopausal Osteoporosis
Fei Wei, Megan Hughes, Mahmoud Omer, Christopher Ngo, Abinaya Sindu Pugazhendhi, Elayaraja Kolanthai, Matthew Aceto, Yasmine S. Ghattas, Mehdi Razavi, Thomas J. Kean et al. · 2024 · Advanced Science
Dimeric R25CPTH(1–34) activates the parathyroid hormone-1 receptor in vitro and stimulates bone formation in osteoporotic female mice
Minsoo Noh, Xiangguo Che, Xian Jin, Dong-Kyo Lee, Hyunju Kim, Doo Ri Park, Soo Young Lee, Hunsang Lee, Thomas James Gardella, Je‐Yong Choi et al. · 2025 · eLife
Role of sclerostin deletion in bisphosphonate-induced osteonecrosis of the jaw
Fuminori Nakashima, Shinji Matsuda, Yurika Ninomiya, Tomoya Ueda, Keisuke Yasuda, Saki Hatano, Shogo Shimada, Daisuke Furutama, Takumi Memida, Mikihito Kajiya et al. · 2024 · Bone
Potential Targeting Mechanisms for Bone-Directed Therapies
Betül Çelik, Andrés Felipe Leal, Shunji Tomatsu · 2024 · International Journal of Molecular Sciences
Verifying the effectiveness of romosozumab re-administration on bone mineral density
Tomonori Kobayakawa, Yukio Nakamura · 2024 · Journal of Bone and Mineral Research
Romosozumab Improves Tissue Thickness–Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes
Serge Ferrari, Donald Betah, Robert G Feldman, Bente Lomholdt Langdahl, Mary K. Oates, Jen Timoshanko, Zhenxun Wang, Ruban Dhaliwal · 2025 · The Journal of Clinical Endocrinology & Metabolism
Identification of NIBAN2‐Regulated RUNX2 Alternative Splicing Presents Novel Strategies for Antagonizing Osteoporosis
Sheng Zhang, Zhiqiang Yang, Yuanlong Xie, Yufeng Zhang, Zhe Chen, Xuan Lv, Zhouming Deng, Zan Huang, Lin Cai, Renxiong Wei · 2025 · Advanced Science
Metformin ameliorates osteoporosis by enhancing bone angiogenesis via the YAP1/TAZ-HIF1α axis
Hao Yin, Zhe Ruan, Tengfei Wan, Zhi-Rou Lin, Chun‐Yuan Chen, Zhenxing Wang, Jia Cao, Yiyi Wang, Ling Jin, Yi-Wei Liu et al. · 2025 · Molecular Medicine
Viridicatol from the Deep‐Sea‐Derived Fungus Alleviates Bone Loss by Targeting the Wnt/SHN3 Pathway
Chun‐Lan Xie, S Ye, Yu‐Ting Yue, Baohong Shi, Jing‐Ping Xu, Lian‐Jie Li, Zheng‐Biao Zou, Matthew Blake Greenblatt, Na Li, Xian‐Wen Yang et al. · 2025 · Advanced Science
Treatment Considerations for Severe Osteoporosis in Older Adults
Heidi See, Emma Gowling, Evie Boswell, Pritti Aggarwal, Katherine King, Nicola Smith, Stephen E R Lim, Mark A Baxter, Harnish P. Patel · 2025 · Drugs & Aging
Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders
Zhiping He, Qingping Peng, Wenying Bin, Luyao Zhao, Yihuang Chen, Yuanqun Zhang, Weihu Yang, Xingchen Yan, Huan Liu · 2025 · Bone Research
Osteoporosis: advances in risk assessment and management
Juliet Elizabeth Compston · 2016 · Clinical Medicine
Liquid chromatography-mass spectrometry method for the quantification of an anti-sclerostin monoclonal antibody in cynomolgus monkey serum
Yuxiong Gao, Zhendong Chen, Changyong Yang, Dafang Zhong · 2020 · Journal of Pharmaceutical Analysis
Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO)
Barbara Campolina Carvalho Silva, Miguel Madeira, Catarina Brasil d’Alva, Sérgio Setsuo Maeda, Narriane Chaves Pereira de Holanda, Monique Nakayama Ohe, Vera Lúcia Szejnfeld, Cristiano A. F. Zerbini, Francisco José Albuquerque de Paula, Francisco Alfredo Farias Bandeira · 2022 · Archives of Endocrinology and Metabolism
Sclerostin ablation prevents aortic valve stenosis in mice
J. Ethan Joll, Lance A. Riley, Matthew R. Bersi, Jeffry Stephen Nyman, W. David Merryman · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases
Edward Michael Lewiecki, John Paul Bilezikian, Neil Binkley, Mary Bouxsein, Susan V. Bukata, David W. Dempster, Matthew T. Drake, Michael R. McClung, Paul D. Miller, Elisabeth A. Rosenthal et al. · 2022 · Journal of Clinical Densitometry
Use of vitamin D with anti-osteoporotic drugs: are available clinical trials telling us the whole story?
Luigi di Filippo, Fabio Massimo Ulivieri, Ranuccio Nuti, Andrea Giustina · 2023 · Endocrine
Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes
Tatiane Vilaça, Richard Eastell · 2023 · JBMR Plus
Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes
Tatiane Vilaça, Richard Eastell · 2023 · Current Osteoporosis Reports
Teriparatide in postmenopausal osteoporosis: uncovering novel insights into efficacy and safety compared to other treatments – a systematic review and meta-analysis
Djandan Tadum Arthur Vithran, Anko Elijah Essien, Masoud Rahmati, Michael Opoku, Dong Keon Yon, Guillermo Felipe López Sánchez, Ai Koyanagi, Lee Smith, Jae Il Shin, Wenfeng Xiao et al. · 2024 · EFORT Open Reviews
Normative values for CT-based texture analysis of vertebral bodies in dual X-ray absorptiometry-confirmed, normally mineralized subjects
Manoj Mannil, Matthias Eberhard, Anton S. Becker, Denise Schönenberg, Georg Osterhoff, Diana Frey, Ender Konukoğlu, Hatem Alkadhi, Roman Guggenberger · 2017 · Skeletal Radiology
Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume
Alyson Morse, Tegan L. Cheng, Aaron Schindeler, Michelle Maree McDonald, Sindhu T. Mohanty, Michaela Kneissel, Ina Krämer, David Graham Little · 2018 · Calcified Tissue International
DObesity: Relationship between vitamin D deficiency, obesity and sclerostin as a novel biomarker of bone metabolism
Eman Azzam, Mohamed Nabil Soliman Atta, Doreen Nazeih Assaad Younan, Tarek Mohamed Salem, Ahmed Alaa Abdul-Aziz · 2019 · Journal of Clinical & Translational Endocrinology
Combination therapy in the Col1a2G610C mouse model of Osteogenesis Imperfecta reveals an additive effect of enhancing LRP5 signaling and inhibiting TGFβ signaling on trabecular bone but not on cortical bone
Shannon M. Kaupp, Daniel J. Horan, Kyung‐Eun Lim, Henry A. Feldman, Alexander G. Robling, Matthew L. Warman, Christina M. Jacobsen · 2019 · Bone
A probable atypical ulnar fracture in a man receiving denosumab
Neil Binkley, Heenam Goel, E. Shives, Diane C. Krueger, Kristyn J. Hare · 2020 · Bone
Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan
Mototsugu TANAKA, Mayumi Idei, Hiroshi Sakaguchi, Ryosuke Kato, Daisuke Sato, Kenji Sawanobori, Shuichi Kawarasaki, Toshiyuki Hata, Asako Yoshizaki, Miki Nakamura et al. · 2021 · British Journal of Clinical Pharmacology
The role of bone‐modifying agents in myeloma bone disease
Huifang Lu, Xerxes Pundole, Hans Chulhee Lee · 2021 · JBMR Plus
Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
Daniel Cejka · 2021 · Metabolites
Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases
Edward Michael Lewiecki, Paul A. Anderson, John Paul Bilezikian, Neil Binkley, Angela M. Cheung, Erik Allen Imel, Diane C. Krueger, Michael R. McClung, Paul D. Miller, Micol Sara Rothman · 2021 · Journal of Clinical Densitometry
Bilateral Atypical Femur Fractures After Denosumab in a Bisphosphonate Naive Patient: A Case Report
Jeremy Keng Meng Goh, Joyce Suang Bee Koh, Alvin Choong Meng Ng, Meng Ai Png, Tet Sen Howe · 2022 · Calcified Tissue International
Soluble interleukin 2 receptor is risk for sarcopenia in Men with high fracture risk
Jiaying Ge, Jiangping Zeng, Nannan Li, Huihui Ma, Zheng Zhao, Siqi Sun, Yujie Jing, Chunhua Qian, Zhaoliang Fei, Shen Qu et al. · 2022 · Journal of Orthopaedic Translation
Treatment of osteoporosis: whom, how and for how long?
Anastasia D. Dede, Margaret F. C. Callan · 2018 · British Journal of Hospital Medicine
New Osteoporosis Treatment Means New Bone Formation
Kala K. Blakely, Cori Johnson · 2019 · Nursing for Women s Health
Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications
Jordi Bover, Pablo Ureña, Ana María Láiz, José‐Vicente Torregrosa, Minerva Rodríguez-García, Cristina Castro-Alonso, José Luis Górriz, Silvia Benito, Víctor López‐Báez, María Jesús Lloret Cora et al. · 2019 · Nefrología (English Edition)
An Overview of Osteoporosis and Possible Treatment Approaches
Mohannad Hakam Hamed Abo-Elenin, Rehab Kamel, Shahira Nofal, Amany A.E. Ahmed · 2024 · Clinical & Translational Metabolism
Osteoporosis treatments for intervertebral disc degeneration and back pain: a perspective
Neharika Bhadouria, Nilsson Holguin · 2024 · JBMR Plus
Monthly treatment with romosozumab for 1 year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury
Laura E. Crack, Narina Simonian, Thomas J. Schnitzer, William Brent Edwards · 2024 · JBMR Plus
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study
Alberto Piasentier, Alessandro Fanti, Maria Francesca Birtolo, Walter Vena, Roberto Colle, Lucrezia Maria Silvana Gentile, Simona Jaafar, Antonio Carlo Bossi, Andrea Gerardo Lania, Gherardo Mazziotti · 2025 · Journal of Endocrinological Investigation
Evolving strategies for osteoporosis management in postmenopausal women: From tradition to innovation
Anum Akbar, Amna Zaheer, Manahil Mansha Kharal, Aqsa Komel, Muhammad Hamza Khan, Areeba Ahsan, Achit Kumar Singh · 2025 · Medicine
Osteoporosis in Men: an Overlooked Patient Population
Sharon Hsiao-Han Chou · 2025 · Current Osteoporosis Reports
Comparative effectiveness of romosozumab versus teriparatide for fracture prevention: A new-user, active comparator design
Ryoji Tominaga, Tatsuyoshi Ikenoue, Ryosuke Ishii, Kakuya Niihata, Tetsuro Aita, T. Okuda, Sayaka Shimizu, Noriaki Kurita, Masataka Taguri · 2025 · Bone
A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis
Yasumori Sobue, Hironobu Kosugiyama, Shuji Asai, Yoshikazu Ogawa, Minoru Yoneda, Koji Maruyama, Mariko Kaneko, Tomonori Kobayakawa, Kenya Terabe, Mochihito Suzuki et al. · 2025 · Scientific Reports
Treatment-related changes in total hip bone mineral density are applicable to trials of varied study designs and to drugs with differing mechanisms of action: meta-regression results from the FNIH-ASBMR SABRE study
Tatiane Vilaça, Li‐Yung Lui, Marian Schini, Susan K. Ewing, Austin R. Thompson, Eric Vittinghoff, Douglas C. Bauer, Dennis M. Black, Mary Bouxsein, Richard Eastell · 2025 · Journal of Bone and Mineral Research
Combined physical and pharmacological anabolic osteoporosis therapies increase bone response and mechanoregulation in female mice
Friederike A. Schulte, Francisco Correia Marques, Julia K. Griesbach, Claudia Weigt, Marcella von Salis‐Soglio, Floor M. Lambers, Clemens Kreutz, Michaela Kneissel, Peter J. Richards, Gisela Anna Kuhn et al. · 2026 · Nature Communications
Successful treatment of humeral shaft nonunion with romosozumab: A case report
Sang Yang Lee, Keikichi Kawasaki, Katsunori Inagaki · 2021 · Trauma Case Reports
The effects of romosozumab combined with active vitamin D3 on fracture healing in ovariectomized rats
Ryota Takase, Yuta Tsubouchi, Takefumi Otsu, Takashi Kataoka, Tatsuya Iwasaki, Masashi Kataoka, Hiroshi Tsumura · 2022 · Journal of Orthopaedic Surgery and Research
A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab
Zepeng Chen, Ming Li, Shuzhen Li, Yuxi Li, Junyan Wu, Kaifeng Qiu, Xiaoxia Yu, Lin Chong Huang, Guanghui Chen · 2022 · Expert Opinion on Drug Safety
High Prevalence of Foot Insufficiency Fractures in Patients With Inflammatory Rheumatic Musculoskeletal Diseases
Bjoern Buehring, Nadine Al-Azem, Uta Kiltz, Martin Fruth, Ioana Andreica, DAVID M. KIEFER, Styliani Tsiami, Xenofon Baraliakos, Jürgen Braun · 2022 · The Journal of Rheumatology
Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta
Juliana Marulanda, Josephine T. Tauer, Iris Boraschi-Diaz, Ghalib K. Bardai, Frank Rauch · 2023 · Scientific Reports
Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal Patients
Tetsuro Oue, Tomohiro Shimizu, Tsuyoshi Asano, Shun Shimodan, Hotaka Ishizu, Kosuke Arita, Norimasa Iwasaki · 2023 · Calcified Tissue International
The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts
Karina E. Pigeaud, Melanie L. Rietveld, Aster F. Witvliet, Jolanda M. A. Hogervorst, Chen Zhang, Tim Forouzanfar, Nathalie Bravenboer, Ton Schoenmaker, Teun J. de Vries · 2023 · International Journal of Molecular Sciences
Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta
Antara Dattagupta, Steven M. Petak · 2023 · AACE Clinical Case Reports
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Sarfaraz K. Niazi · 2023 · Pharmaceuticals
The Role of TAM Receptors in Bone
Janik Engelmann, Deniz Ragipoglu, Isabel Ben Batalla, Sonja Loges · 2023 · International Journal of Molecular Sciences
Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells
Cyril Thouverey, Pierre Apostolides, Julia Brun, Joseph Caverzasio, Serge Ferrari · 2024 · JCI Insight
Effect of romosozumab administration on proximal junctional kyphosis in corrective spinal fusion surgery
Yuta Sawada, Shinji Takahashi, Hiroyuki Yasuda, Masaki Terakawa, Sadahiko Konishi, Minori Kato, Hiromitsu Toyoda, Akinobu Suzuki, Koji Tamai, Masayoshi Iwamae et al. · 2024 · The Spine Journal
Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop
Leanne Marie Ward, Kathi Kinnett, Lynda Faye Bonewald, Jonathan Derrick Adachi, Laura K. Bachrach, Teresita Bellido, Marco A. P. Brotto, Lynda Faye Bonewald, Joanne M. Donovan, Eric P. Hoffman et al. · 2017 · Neuromuscular Disorders
WNT-activated bone grafts repair osteonecrotic lesions in aged animals
Benjamin Jean Rene Salmon, B. Liu, Enpu Shen, T. Chen, Jingtao Li, M. Gillette, Ryan C. Ransom, M. Ezran, Chelsey A. Johnson, Alesha B. Castillo et al. · 2017 · Scientific Reports
Sost deficiency leads to reduced mechanical strains at the tibia midshaft in strain-matched in vivo loading experiments in mice
Laia Albiol, Myriam Cilla, David Pflanz, Ina Krämer, Michaela Kneissel, Georg N. Duda, Bettina M. Willie, Sara Checa · 2018 · Journal of The Royal Society Interface
Overcoming natural Wnt inhibition to optimize therapy
Natalie A. Sims · 2019 · Nature Reviews Rheumatology
Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review
Simon Walz, Moritz Maas, Arnulf Stenzl, Tilman Todenhöfer · 2019 · The World Journal of Men s Health
Prevention and treatment of osteoporosis in women
Gabriella Shanks, Devina Sharma, Vinita Mishra · 2019 · Obstetrics Gynaecology & Reproductive Medicine
Histological functions of parathyroid hormone on bone formation and bone blood vessels
Haruhi Maruoka, Tomomaya Yamamoto, Shen Zhao, Hiromi Hongo, Miki Abe, Hotaka Ishizu, Hirona Yoshino, Paulo Henrique Luiz de Freitas, Minqi Li, Tomoka Hasegawa · 2022 · Journal of Oral Biosciences
Denosumab Versus Bisphosphonates for the Prevention of the Vertebral Fractures in Men with Osteoporosis: An Updated Network Meta-Analysis
Pengfei Li, Xiaojian Wu, Ye Li, Jianhua Huang · 2022 · Clinical and investigative medicine
Prediabetes and Fracture Risk Among Midlife Women in the Study of Women’s Health Across the Nation
Albert Shieh, Gail A. Greendale, Jane A. Cauley, Carrie A Karvonen-Gutierrez, Arun S. Karlamangla · 2023 · JAMA Network Open
Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial
Yuxin Zheng, Xuezong Wang, Zongkang Zhang, Baosheng Guo, Lei Dang, Bing He, Chi Zhang, Jiwei Zhou, Wanzhong Shi, Yongfang Zhao et al. · 2019 · Scientific Reports
Postmenopausal Osteoporosis
Antonio Cano, Miguel Ángel García‐Pérez · 2017 · Springer eBooks
Comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”
Hilma Hólm, Patrick Sulem, Vinicius Tragante, Unnur Þorsteinsdóttir, Daniel Fannar Gudbjartsson, Kāri Stefánsson · 2021 · Science Translational Medicine
Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health
Yasser M El Miedany, Walaa Elwakil, Mohammed Hassan Abu-Zaid, Safaa Mahran · 2024 · Egyptian Rheumatology and Rehabilitation
In vitro and in vivo studies on exogenous polyamines and α-difluoromethylornithine to enhance bone formation and suppress osteoclast differentiation
Chien-Ching Lee, Chia-Chun Chuang, Chung‐Hwan Chen, Yuan-Pin Huang, Chiao-Yi Chang, Pei-Yi Tung, Mon‐Juan Lee · 2024 · Amino Acids
Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease
Holly Evans, Rebecca E. Andrews, Fatma Ali Abedi, Alexandria R. Sprules, Jacob Trend, Goran Lovrić, Alanna Green, Andrew Chantry, Claire Elizabeth Clarkin, Janet Elizabeth Brown et al. · 2024 · JBMR Plus
Efficacy and safety of sequential therapy for primary osteoporosis with bone formation promoters followed by bone resorption inhibitors: a meta-analysis
Yuxin Liu, Xin Liu, Yuefeng Wu, Tao Luo · 2025 · Journal of Orthopaedic Surgery and Research
Optimisation of romosozumab plus denosumab sequential treatments against postmenopausal osteoporosis. Insights from in silico simulations
Rocío Ruiz-Lozano, José Luis Calvo‐Gallego, Peter Pivonka, Javier Martínez‐Reina · 2025 · Biomechanics and Modeling in Mechanobiology
Osteoporosis in Adult Patients Undergoing Spinal Reconstructive Surgery: Associated Complications and Management
Zeeshan Mohammad Sardar, Josephine Rose Coury, David W. Polly, Kmc Cheung, Stephen J. Lewis, AO Spine Knowledge Forum Deformity · 2025 · Global Spine Journal
Osteoblasts in bone metastasis: Key players in the tumor microenvironment and therapeutic targets
Lingxiao Jin, Zhenxuan Shao, Zhaoming Ye, Binghao Li · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
A systematic review and meta-analysis of sequential treatment strategies for osteoporosis
Smita Nayak, Susan L. Greenspan · 2025 · Osteoporosis International
Romosozumab Enhances Implant Stability in Glucocorticoid-Induced Osteoporotic Bone: A Rabbit Model Study
Ji-Won Kwon, Seong-Hwan Moon, Kyung‐Soo Suk, Si-Young Park, Hak‐Sun Kim, Sub-Ri Park, Namhoo Kim, B. Lee · 2025 · Neurospine
Secondary fracture prevention: Drug treatment, fall prevention and nutrition requirements
Piet Geusens, Willem Frederik Lems, S. Bours, Joop P. van den Bergh · 2019 · Best Practice & Research Clinical Rheumatology